{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:21Z","timestamp":1790912841406,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000013"],"award-info":[{"award-number":["MOH-000013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF2017_SISFP09"],"award-info":[{"award-number":["NRF2017_SISFP09"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022896","name":"Singapore Immunology Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbi.2024.10.019","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T06:24:30Z","timestamp":1728887070000},"page":"656-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Immunophenotyping schizophrenia subtypes stratified by antipsychotic response"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-125X","authenticated-orcid":false,"given":"Yanhui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn Wen Xin","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen Mei","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Yin","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmaine","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Tat","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernett Teck Kwong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Rotzschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Kumar","family":"Andiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.10.019_b0005","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41590-020-0776-4","article-title":"Meningeal \u03b3\u03b4 T cells regulate anxiety-like behavior via IL-17a signaling in neurons","volume":"21","author":"Alves de Lima","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbi.2024.10.019_b0010","series-title":"Diagnostic And Statistical Manual Of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.bbi.2024.10.019_b0015","doi-asserted-by":"crossref","unstructured":"Andreasen, N.C., 2010. Concept of Schizophrenia: Past, Present, and Future, in: Schizophrenia. John Wiley & Sons, Ltd, pp. 1\u20138. https:\/\/doi.org\/10.1002\/9781444327298.ch1.","DOI":"10.1002\/9781444327298.ch1"},{"key":"10.1016\/j.bbi.2024.10.019_b0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1192\/pb.21.4.224","article-title":"Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications","volume":"21","author":"Atkins","year":"1997","journal-title":"Psychiatric Bulletin"},{"key":"10.1016\/j.bbi.2024.10.019_b0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society: Series B (methodological)"},{"key":"10.1016\/j.bbi.2024.10.019_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-9964(97)00153-9","article-title":"Increased levels of CD8+ and CD4 + 45RA + lymphocytes in schizophrenic patients","volume":"31","author":"Cazzullo","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/157340006778699729","article-title":"Trait vs. State Markers for Schizophrenia: Identification and Characterization Through Visual Processes","volume":"2","author":"Chen","year":"2006","journal-title":"Current Psychiatry Reviews"},{"key":"10.1016\/j.bbi.2024.10.019_b0040","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.1302701","article-title":"Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus","volume":"193","author":"Cho","year":"2014","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0045","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options","volume":"82","author":"Correll","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neubiorev.2021.03.004","article-title":"Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia","volume":"125","author":"Corsi-Zuelli","year":"2021","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.bbi.2024.10.019_b0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0278-5846(96)00100-5","article-title":"Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy","volume":"20","author":"Cosentino","year":"1996","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0060","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1371\/journal.pone.0000692","article-title":"Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease Mechanisms","volume":"2","author":"Craddock","year":"2007","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bbi.2024.10.019_b0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/08039488.2016.1141981","article-title":"Chemokine gene variants in schizophrenia","volume":"70","author":"Dasdemir","year":"2016","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0070","first-page":"1003","article-title":"An analysis of lymphocyte subpopulations in schizophrenic patients","volume":"17","author":"DeLisi","year":"1982","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","article-title":"Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia","volume":"169","author":"Demjaha","year":"2012","journal-title":"AJP"},{"key":"10.1016\/j.bbi.2024.10.019_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0085","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1681\/ASN.V44976","article-title":"CD45 and the immune response","volume":"4","author":"Donovan","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bbi.2024.10.019_b0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1017\/S1461145710001653","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"14","author":"Drexhage","year":"2011","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2024.10.019_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878997","article-title":"Exploration of the relationship between hippocampus and immune system in schizophrenia based on immune infiltration analysis","volume":"13","author":"Du","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.880568","article-title":"Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives","volume":"13","author":"Ermakov","year":"2022","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114250","article-title":"New insights into MAIT cells in autoimmune diseases","volume":"159","author":"Fan","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.bbi.2024.10.019_b0110","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1007\/s00018-019-03255-6","article-title":"Dual CCR5\/CCR2 targeting: opportunities for the cure of complex disorders","volume":"76","author":"Fantuzzi","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbi.2024.10.019_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155631","article-title":"Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia","volume":"11","author":"Fernandez-Egea","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2024.10.019_b0120","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgae018","article-title":"Biomarkers for psychosis: are we there yet? Umbrella review of 1478 biomarkers","author":"Fuentes-Claramonte","year":"2024","journal-title":"Schizophrenia Bulletin Open sgae018."},{"key":"10.1016\/j.bbi.2024.10.019_b0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-1781(93)90114-V","article-title":"CD5 positive B lymphocytes in schizophrenia: No alteration in numbers or percentage as compared with control subjects","volume":"48","author":"Ganguli","year":"1993","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41380-021-01362-0","article-title":"Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia","volume":"27","author":"Gao","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0135","doi-asserted-by":"crossref","unstructured":"Gargano, F., Guerrera, G., Piras, E., Serafini, B., Di Paola, M., Rizzetto, L., Buscarinu, M.C., Annibali, V., Vuotto, C., De Bardi, M., D\u2019Orso, S., Ruggieri, S., Gasperini, C., Pavarini, L., Ristori, G., Picozza, M., Rosicarelli, B., Ballerini, C., Mechelli, R., Vitali, F., Cavalieri, D., Salvetti, M., Angelini, D.F., Borsellino, G., De Filippo, C., Battistini, L., 2022. Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain. Frontiers in Immunology 13.","DOI":"10.3389\/fimmu.2022.890298"},{"key":"10.1016\/j.bbi.2024.10.019_b0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbi.2023.10.001","article-title":"Changes in immunoglobulin levels during clozapine treatment in schizophrenia","volume":"115","author":"Griffiths","year":"2024","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.bbi.2024.10.019_b0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0447.2007.01103.x","article-title":"Assessment of remission in schizophrenia with the CGI and CGI-SCH scales","volume":"117","author":"Haro","year":"2008","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.bbi.2024.10.019_b0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/h0071325","article-title":"Analysis of a complex of statistical variables into principal components","volume":"24","author":"Hotelling","year":"1933","journal-title":"Journal of Educational Psychology"},{"key":"10.1016\/j.bbi.2024.10.019_b0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"AJP"},{"key":"10.1016\/j.bbi.2024.10.019_b0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11481-011-9309-0","article-title":"Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation","volume":"7","author":"Hu","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.bbi.2024.10.019_b0165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.schres.2018.04.026","article-title":"Further evidence for depletion of peripheral blood natural killer cells in patients with schizophrenia: A computational deconvolution study","volume":"201","author":"Karpi\u0144ski","year":"2018","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.06.002","article-title":"Immune system aberrations in postpartum psychosis: An immunophenotyping study from a tertiary care neuropsychiatric hospital in India","volume":"310","author":"Kumar","year":"2017","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0180","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ni.1890","article-title":"Antimicrobial activity of mucosal-associated invariant T cells","volume":"11","author":"Le Bourhis","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbi.2024.10.019_b0185","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/JCP.0000000000000387","article-title":"The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study","volume":"35","author":"Lee","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bbi.2024.10.019_b0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1176\/appi.focus.140306","article-title":"Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms","volume":"14","author":"Lee","year":"2016","journal-title":"FOC"},{"key":"10.1016\/j.bbi.2024.10.019_b0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.schres.2014.08.018","article-title":"A genetic locus in 7p12.2 associated with treatment resistant schizophrenia","volume":"159","author":"Li","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0200","doi-asserted-by":"crossref","first-page":"e33598","DOI":"10.1371\/journal.pone.0033598","article-title":"Genome-Wide Association Study of Treatment Refractory Schizophrenia in Han Chinese","volume":"7","author":"Liou","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bbi.2024.10.019_b0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17816\/CP66","article-title":"Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia","volume":"2","author":"Malashenkova","year":"2021","journal-title":"Consortium Psychiatricum"},{"key":"10.1016\/j.bbi.2024.10.019_b0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrneurol.2015.248","article-title":"CCR5 blockade for neuroinflammatory diseases \u2014 beyond control of HIV","volume":"12","author":"Martin-Blondel","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bbi.2024.10.019_b0215","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1093\/schbul\/sbz021.253","article-title":"O10.5. meta-analysis of cytokine levels and psychopathology in schizophrenia","volume":"45","author":"Miller","year":"2019","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbi.2024.10.019_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2019.100006","article-title":"Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology","volume":"1","author":"Miller","year":"2019","journal-title":"Biomarkers in Neuropsychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0225","first-page":"993","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biological Psychiatry, Schizophrenia, Context, and Memory"},{"key":"10.1016\/j.bbi.2024.10.019_b0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/npp.2016.211","article-title":"Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.bbi.2024.10.019_b0235","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/1352458515621796","article-title":"RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis","volume":"22","author":"Mori","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.bbi.2024.10.019_b0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/15622970009150588","article-title":"Cellular and Humoral Immune System in Schizophrenia: A Conceptual Re-Evaluation","volume":"1","author":"M\u00fcller","year":"2000","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.30100","article-title":"MCP-1 gene (SCYA2) and schizophrenia: A case-control association study","volume":"132B","author":"Mundo","year":"2005","journal-title":"American Journal of Medical Genetics Part b: Neuropsychiatric Genetics"},{"key":"10.1016\/j.bbi.2024.10.019_b0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/sji.12193","article-title":"The Decrease in Number and Change in Phenotype of Mucosal-Associated Invariant T cells in the Elderly and Differences in Men and Women of Reproductive Age","volume":"80","author":"Novak","year":"2014","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0255","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00439-016-1706-2","article-title":"Immunoglobulin G genotypes and the risk of schizophrenia","volume":"135","author":"Pandey","year":"2016","journal-title":"Hum Genet"},{"key":"10.1016\/j.bbi.2024.10.019_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01079","article-title":"CCL5\u2013Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis","volume":"8","author":"Pittaluga","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0265","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1134\/S1022795423070086","article-title":"Pilot Study to Detect the Repertoires of T-Cell Receptor Gamma Chains in Patients with Juvenile Schizophrenia","volume":"59","author":"Plotnikova","year":"2023","journal-title":"Russian Journal of Genetics"},{"key":"10.1016\/j.bbi.2024.10.019_b0270","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l483","article-title":"Antibody deficiency in patients taking clozapine","author":"Ponsford","year":"2019","journal-title":"BMJ l483."},{"key":"10.1016\/j.bbi.2024.10.019_b0275","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/jclinpath-2019-206235","article-title":"Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)","volume":"73","author":"Ponsford","year":"2020","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.bbi.2024.10.019_b0280","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1017\/ice.2020.163","article-title":"Effective infection prevention and control strategies in a large, accredited, psychiatric facility in Singapore","volume":"41","author":"Poremski","year":"2020","journal-title":"Infection Control & Hospital Epidemiology"},{"key":"10.1016\/j.bbi.2024.10.019_b0285","unstructured":"R Core Team, 2022. R: A language and environment for statistical computing."},{"key":"10.1016\/j.bbi.2024.10.019_b0290","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1038\/s41380-021-01244-5","article-title":"Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses","volume":"26","author":"R\u00e4uber","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0531-5565(98)00058-8","article-title":"CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-\u03b1, IFN-\u03b3, and sIL-2R levels in aging","volume":"34","author":"Rea","year":"1999","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.bbi.2024.10.019_b0300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far?","volume":"140","author":"R\u00f8ge","year":"2012","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0305","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000026501","article-title":"Immunological Dysfunction in Schizophrenia: A Systematic Approach","volume":"37","author":"Rothermundt","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbi.2024.10.019_b0310","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00213-020-05504-0","article-title":"Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia","volume":"237","author":"Sahbaz","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2024.10.019_b0315","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00920243","article-title":"Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells","volume":"13","author":"Schedlowski","year":"1993","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbi.2024.10.019_b0320","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41423-020-0511-y","article-title":"A recently described type 2 conventional dendritic cell (cDC2) subset mediates inflammation","volume":"17","author":"Shin","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bbi.2024.10.019_b0325","unstructured":"Singapore Department of Statistics, 2020. Singapore Census of Population 2020."},{"key":"10.1016\/j.bbi.2024.10.019_b0330","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/acps.13361","article-title":"Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis","volume":"144","author":"Siskind","year":"2021","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.bbi.2024.10.019_b0335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0920-9964(98)00175-3","article-title":"T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients","volume":"38","author":"Sperner-Unterweger","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0340","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00406-010-0098-x","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","volume":"260","author":"Steiner","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbi.2024.10.019_b0345","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbi.2012.01.018","article-title":"Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels","volume":"26","author":"Steiner","year":"2012","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.bbi.2024.10.019_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121124","article-title":"Mucosal-Associated Invariant T Cell Is a Potential Marker to Distinguish Fibromyalgia Syndrome from Arthritis","volume":"10","author":"Sugimoto","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bbi.2024.10.019_b0355","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2006.00749.x","article-title":"Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies","volume":"115","author":"Szczuci\u0144ski","year":"2007","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.bbi.2024.10.019_b0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00401-006-0083-7","article-title":"Chemokine expression by astrocytes plays a role in microglia\/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis","volume":"112","author":"Tanuma","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bbi.2024.10.019_b0365","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","article-title":"Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1","volume":"422","author":"Treiner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2024.10.019_b0370","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Tr\u00e9panier","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0375","doi-asserted-by":"crossref","first-page":"s18","DOI":"10.1192\/bjp.178.40.s18","article-title":"Genes, environment and schizophrenia","volume":"178","author":"Tsuang","year":"2001","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0380","first-page":"e12","article-title":"Immunophenotypes of schizophrenia and psychosis","volume":"66","author":"Turner","year":"2017","journal-title":"Brain, Behavior, and Immunity, PsychoNeuroImmunology Research Society\u2019s 24th Annual Scientific Meeting"},{"key":"10.1016\/j.bbi.2024.10.019_b0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cellimm.2006.12.001","article-title":"CCR5 expression on monocytes and T cells: Modulation by transmigration across the blood\u2013brain barrier in vitro","volume":"243","author":"Ubogu","year":"2006","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0390","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0395","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbi.2019.06.043","article-title":"B-cells and schizophrenia: A promising link or a finding lost in translation?","volume":"81","author":"van Mierlo","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.bbi.2024.10.019_b0400","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2012-201956","article-title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","volume":"72","author":"van Vollenhoven","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.bbi.2024.10.019_b0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2019.08.013","article-title":"Th17 and MAIT cell mediated inflammation in antipsychotic free schizophrenia patients","volume":"212","author":"Varun","year":"2019","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbi.2024.10.019_b0410","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41398-023-02507-1","article-title":"Differences in white blood cell proportions between schizophrenia cases and controls are influenced by medication and variations in time of day","volume":"13","author":"Villar","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0415","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0425","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/cn400121z","article-title":"Classics in Chemical Neuroscience: Clozapine","volume":"4","author":"Wenthur","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbi.2024.10.019_b0430","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/schbul\/sbx175","article-title":"Study of Novel Autoantibodies in Schizophrenia","volume":"44","author":"Whelan","year":"2018","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.bbi.2024.10.019_b0435","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/eji.201344160","article-title":"CD8+ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis","volume":"44","author":"Willing","year":"2014","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.bbi.2024.10.019_b0440","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbi.2024.10.019_b0445","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1471-4159.2010.07121.x","article-title":"Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices","volume":"116","author":"Zhou","year":"2011","journal-title":"Journal of Neurochemistry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124006603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124006603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:39:29Z","timestamp":1747867169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124006603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":89,"alternative-id":["S0889159124006603"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.10.019","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunophenotyping schizophrenia subtypes stratified by antipsychotic response","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}